Abstract-Biomechanical stress ie, attributable to pressure overload, leads to cardiac hypertrophy and may ultimately cause heart failure. Yet, it is still unclear how mechanical stress is sensed and transduced on the molecular level. To systematically elucidate the underlying signal transduction pathways, we analyzed the gene expression profile of stretched cardiomyocytes on a genome-wide scale in comparison with other inducers of hypertrophy such as pharmacological stimulation. Neonatal rat ventricular cardiomyocytes were either stretched biaxially or stimulated with phenylephrine (PE), both resulting in a similar degree of hypertrophy. Microarray analyses revealed 164 genes Ͼ2.0-fold up-and 21 genes Ͻ0.5-fold downregulated (PϽ0.01). Differential expression was confirmed by real-time polymerase chain reaction. Genes of the "fetal gene program" such as BNP were induced by both stretch (4.2ϫ) and PE (2.9ϫ). We also verified upregulation of known stretch-responsive genes, including HSP70 (20.9ϫ) and c-myc (3.0ϫ). Moreover, several genes were found to be preferentially induced by stretch, such as the cardioprotective cytokine GDF15 (24.8ϫ) and heme oxygenase 1 (Hmox1, 10.8ϫ; both confirmed on protein level). Neither PE nor endothelin-1 upregulated GDF15 and Hmox1, whereas angiotensin II significantly induced both genes. Conversely, the AT 1 receptor blocker irbesartan markedly blunted stretch-mediated GDF15 and Hmox1 upregulation, suggesting that the angiotensin receptor tranduces the biomechanical induction of these genes. In conclusion, we report a comprehensive gene expression profile of cardiomyocytes subjected to biomechanical stress in comparison with pharmacologically induced hypertrophy. Our data imply that a stretch-specific gene program exists, which is mediated, at least in part, by angiotensin II-dependent signaling. Key Words: hypertrophy Ⅲ gene expression Ⅲ microarray analysis Ⅲ stress Ⅲ mechanical C ardiac hypertrophy can be induced either by intrinsic stimuli, ie, by inherited mutations of contractile proteins leading to hypertrophic cardiomyopathy or by extrinsic stimuli such as chronic biomechanical stress attributable to arterial hypertension or valvular heart disease. 1 Long standing left ventricular hypertrophy leads to progressive remodeling with fibrosis and cardiomyocyte apoptosis, 2 ultimately resulting in ventricular dilation, heart failure, and increased susceptibility to malignant arrhythmias. 3 Accordingly, cardiac hypertrophy has been shown to be an independent and powerful predictor of cardiovascular morbidity and mortality. 4 -6 The typical cellular features of cardiac hypertrophy comprise an increase in cardiomyocyte size associated with enhanced sarcomerogenesis and protein synthesis, as well as activation of the "fetal" or "hypertrophic" gene program, including the natriuretic peptides ANF and BNP. 7 However, it is still unclear how biomechanical stress, ie, attributable to pressure overload, is sensed and transduced toward initiation of cardiomyocyte hypertrophy. Recently, it has been proposed that a putative stretch receptor is localized at the sarcomeric Z-disc, 8 
C ardiac hypertrophy can be induced either by intrinsic stimuli, ie, by inherited mutations of contractile proteins leading to hypertrophic cardiomyopathy or by extrinsic stimuli such as chronic biomechanical stress attributable to arterial hypertension or valvular heart disease. 1 Long standing left ventricular hypertrophy leads to progressive remodeling with fibrosis and cardiomyocyte apoptosis, 2 ultimately resulting in ventricular dilation, heart failure, and increased susceptibility to malignant arrhythmias. 3 Accordingly, cardiac hypertrophy has been shown to be an independent and powerful predictor of cardiovascular morbidity and mortality. 4 -6 The typical cellular features of cardiac hypertrophy comprise an increase in cardiomyocyte size associated with enhanced sarcomerogenesis and protein synthesis, as well as activation of the "fetal" or "hypertrophic" gene program, including the natriuretic peptides ANF and BNP. 7 However, it is still unclear how biomechanical stress, ie, attributable to pressure overload, is sensed and transduced toward initiation of cardiomyocyte hypertrophy. Recently, it has been proposed that a putative stretch receptor is localized at the sarcomeric Z-disc, 8 involving proteins such as muscle LIM protein (MLP) 9 and Calsarcin-1. 10 Similarly, the integrinbinding proteins Melusin 11 and focal adhesion kinase (FAK), 12 2 proteins of the adjacent costamere, have been implicated in mechanotransduction. Furthermore, the Na ϩ /H ϩ exchanger 13 and gadolinium-blockable stretch-dependent channels 14, 15 also mediate mechanically induced hypertrophy. Thus, biomechanical load appears to be a critical stimulus in the induction of myocardial hypertrophy. 16, 17 However, neurohumoral pathways including adrenergic signals, 18 the reninangiotensin-aldosterone system (RAAS), 19 and endothelin-1 (ET1)-dependent signaling 20 may also contribute to the development of cardiomyocyte hypertrophy. In an in vivo setting it is therefore often impossible to distinguish between the direct effects of increased biomechanical load and secondary neurohumoral activation. To directly assess the mo-lecular pathways which are involved in stretch-dependent signaling, we set up an in vitro stretch experiment using neonatal rat cardiomyocytes. For comparison, we included cardiomyocytes stimulated by phenylephrine to detect genes with stretch-specific regulation. Using a genome wide gene expression screen, a distinct stretch-induced gene expression pattern could be identified. The differentially regulated genes included several established members of the hypertrophic gene program. Interestingly, we also discovered genes with stretch-specific induction, which could not be induced on phenylephrine or endothelin-1 treatment. Of note, angiotensin II (Ang II) was capable of stimulating these genes, whereas the angiotensin II type 1(AT 1 ) receptor blocker irbesartan blocked stretch-mediated induction. Thus, we conclude that a stretch-specific gene expression program exists, which is mediated, at least in part, via AT 1 receptor-dependent signaling.
Materials and Methods
The experimental procedures of the preparation of neonatal cardiomyocytes, cardiomyocyte stretching, RNA isolation and purification, microarray hybridization and microarray data analyses, real-time PCR analyses of gene expression, Northern and immunoblotting, as well as immunofluorescence experiments are provided in the online methods supplement. All results are shown as the meanϮSD. Real time PCR data analyses were carried out using the ⌬⌬ct method. 21 Statistical significance was determined using ANOVA followed by Bonferroni post-hoc test, 2-sided Student unpaired t test or Fisher exact test. PϽ0.05 or less was considered statistically significant.
Results

Biomechanical Stress Results in Significant Cardiomyocyte Hypertrophy
Biomechanical stress is a known inductor of cardiac hypertrophy. However, the coactivation of several neurohumoral signaling pathways makes it difficult to delineate a stretchspecific gene expression profile in vivo. To specifically dissect biomechanical stress pathways, we biaxially stretched purified NRVCMs up to 112% of baseline length for 24 hours. Cardiomyocytes treated with 50 mol/L Phenylephrine (PE) and unstretched cardiomyocytes served as controls.
Stretching and treatment with PE resulted in a comparable degree of cellular hypertrophy as shown in immunofluorescence experiments ( Figure 1A ). In both cases, cell size, sarcomeric organization, as well as expression of the atrial natriuretic factor ( Figure 1B ) were significantly increased in comparison to unstretched cells. In stretched cells, cell surface area ( Figure 1C ) was augmented 1.88-fold, P versus control Ͻ0.001. Gain in cell surface area in PE-treated cell was very similar (1.85-fold, P versus control Ͻ0.001, P versus stretch n.s.). Members of the hypertrophic gene program, such as atrial natriuretic factor ( Figure 1B and 1D) and beta myosin heavy chain were also induced to a similar degree both by stretch and phenylephrine ( Figure 1D ).
Distinct Gene Expression Profile in Cardiomyocyte Hypertrophy Attributable to Biomechanical Stress
To gain a comprehensive view of differentially regulated genes in response to both biomechanical stress and pharmacological induction of hypertrophy, we performed genome wide gene expression screens using Affymetrix 230.2 rat microarrays. Bayes analyses of the raw data revealed 185 differentially regulated genes in the stretch group (a posteriori probability of Ͼ99%). 164 of these genes were significantly and more than 2.0-fold upregulated ( Figure 2A and Table S2 , available online at http://hyper.ahajournals.org), whereas 21 were significantly downregulated (less than 0.5-fold; Figure 2A and Table S2 ). In contrast, stimulation with PE resulted in 450 significantly regulated genes (238 genes more than 2.2-fold upregulated and 211 less than 0.45-fold downregulated; Figure 2B and Table S3 ). Next, the resulting data were normalized and displayed in heat maps, revealing highly reproducible results within groups and a low variance between microarray hybridizations ( Figure 2C for stretch, Figure 2D for phenylephrine). For genes differentially regulated by biaxial stretch (Figure 2A ), hierarchical clustering of the results showed that approximately 50% of these genes were upregulated to a similar degree by PE (upper part of figure 2C ). Moreover, a cluster of multiple genes displayed stretch-specific upregulation (Figure 2C , lower half). In contrast, genes downregulated by biomechanical stress were also downregulated by phenylephrine (lowest lanes in Figure 2C) . When applying hierarchical clustering to genes significantly regulated by phenylephrine ( Figure 2D ), we again observed that the gene expression profiles of stretch-and PE-induced cardiomyocyte hypertrophy clearly differed. Only a few of the genes significantly induced by PE were also increased by mechanical stretch to similar levels (upper lanes of Figure 2D ). Yet, the majority of the PE-regulated transcripts were not significantly altered or even inversely regulated by stretch.
Thus, the microarray analyses revealed distinct differences in the gene expression pattern between stretch-and pharmacologically induced hypertrophy, suggesting that a stretchspecific gene program may exist.
Identification of Genes Specifically Induced by Biomechanical Stretch
To verify differential regulation of individual genes and ESTs in stretched cardiomyocytes we performed real-time PCR analyses. First, we confirmed the induction of several members of the "hypertrophic" gene program, for which an upregulation on prohypertrophic stimuli has been described before. 22 The array data predicted the upregulation of ANF, BNP, FHL-1, BNIP3, and alpha skeletal actin (Table 1) . We selected ANF, BNP, and FHL-1 for further real-time PCR analyses and confirmed significant upregulation of all 3 candidates (Figure 3 ). Biaxial stretch led to 5.1-fold induction of ANF ( Figure 3A , PϽ0.001), whereas PE induced ANF 5.7-fold (PϽ0.001). Biomechanical stress resulted in 4.2-fold upregulation of BNP ( Figure 3B , PϽ0.001), whereas PE induced BNP 2.9-fold (PϽ0.001). Likewise, the 4-and-ahalf-LIM domains protein FHL-1 was significantly upregulated by both stretch ( Figure 3C, 8 .0-fold, PϽ0.01) and PE (9.0-fold, PϽ0.01).
Next, we aimed to identify genes preferentially regulated in stretch-induced cardiomyocyte hypertrophy but not on pharmacological stimulation. Therefore, genes were chosen that fulfilled the following criteria: (1) The ratio of n-fold induction by stretch and n-fold induction by PE exceeded 2.0 and (2) induction by phenylephrine was less than 2.0ϫ. A subset of 24 of 164 stretch-induced genes met these criteria and were thus considered to be candidate members of a stretch-specific gene program (summarized in Table 2 ). To further validate these findings, we carried out real-time PCR experiments for the genes with the strongest induction by stretch. All genes and ESTs examined by real-time PCR were found upregulated to a similar degree as predicted by the microarrays, confirming the accuracy of the latter experiment ( Figure 4 ).
Heat shock protein 70 (HSP 70, Figure 4A ) displayed a marked regulation on stretch (20.9-fold, PϽ0.001 versus control), whereas PE only modestly induced HSP 70 (1.7-fold; PϽ0.001 versus stretch). Of note, HSP 70 as well as the protooncogene c-myc ( Figure 4B , 3.0-fold induction by stretch, PϽ0.001) were among the first genes previously identified as stretch-responsive, 23, 24 confirming the reliability of our biomechanical stress model. In addition, several genes selectively induced by biomechanical stress could be identified, which have not been implicated in cardiomyocyte hypertrophy before: The positive regulator of cell cycle progression CKS2 (Cyclin dependent kinase regulatory subunit 2, Figure 4C ) was found 5.8-fold upregulated by stretch (PϽ0.001 versus control), yet downregulated 0.6-fold by PE. Similarly, monoaminooxidase A (MaoA, Figure 4D ) was induced 3.9-fold by stretch (PϽ0.001 versus control) but downregulated by PE. Moreover, the noncoding RNA VL30 ( Figure 4E ), implicated in gene regulation, 25 was induced 5.2-fold by stretch (PϽ0.001 versus control) but not PE. Interestingly, several antioxidative and cardioprotective factors were markedly and stretch-specifically upregulated, such as metallothionein 1a ( Figure 4F , 17.7-fold; PϽ0.001 versus control). Likewise, heme oxidase-1 (Hmox1, Figure 4G ) also ranked among the most specifically regulated gene transcripts and was found induced by stretch 10.8-fold (PϽ0.05 versus control), whereas PE left the level of Hmox1 unchanged. The strongest upregulation was observed for the cytokine growth and differentiation factor 15 (GDF15 or Mic-1, Figure 4H ), which was induced 24.8-fold through stretch (PϽ0.05 versus control), but not significantly regulated by phenylephrine. We further asked whether the highly induced genes GDF15 and heme oxidase-1 were upregulated on the protein level as well. Both GDF15 and Hmox1 indeed displayed a pronounced induction on stretch ( Figure 4I and 4J), whereas phenylephrine failed to induce significant upregulation. In addition to the known genes described above, the microarray analyses also revealed several differentially regulated ESTs. Selective induction on biomechanical stress could be confirmed for all Figure S1 ), further supporting the notion of a stretch-specific gene program.
tested transcripts (
Finally, the expression levels of genes predicted to be downregulated on stretch were also determined by real-time RCR. Lipocalin 2, also named neutrophil gelatinase associated lipocalin, a protein induced in atherosclerosis and myocardial infarction, 26 was found downregulated Ϫ86% by stretch (PϽ0.001) and Ϫ81% by PE (PϽ0.001 versus control, Figure 4K ). The cardiac gap junction protein connexin-40 (Gja5) was decreased to 40% of the control on stretch (PϽ0.001) and to 18% by PE treatment (PϽ0.001 versus control, PϽ0.05 versus stretch, Figure 4L ). Similarly, expression of the cell adhesion molecule VCAM1 (Ϫ59% by stretch, PϽ0.001; Ϫ76% by PE, PϽ0.001 versus control, Figure 4M ), and phospholipase 2A (Ϫ91% by stretch, PϽ0.001; Ϫ80% by PE, PϽ0.001 versus control, PϽ0.05 versus stretch, Figure 4N ) were markedly depressed both by stretch and PE. In contrast to the upregulated transcripts, none of the downregulated genes were specifically repressed by stretch.
Stretch-Specific Gene Expression Is Mediated by Ang II Receptor Signaling
To further confirm that the observed changes in gene expression were specific for biomechanical stress, we also tested whether other pharmacological stimulators of cardiomyocyte hypertrophy, such as ET1 and Ang II, were able to induce these genes. We thus treated NRVCMs with 100 nmol/L ET1 or 100 nmol/L Ang II, respectively. As a control, we again included NRVCMs stimulated with 50 mol/L phenylephrine in this experiment. All 3 agents induced hypertrophy to a similar degree ( Figure S2 ) and led to strong induction of members of the hypertrophic gene program, including ANF (Ang II: 5.0-fold, PϽ0.05; ET1: 7.6-fold, PϽ0.01; PE: 6.7-fold, PϽ0.01) and BNP (Ang II: 9.0-fold, Pϭ0.03; ET1: 3.8-fold, pϭn.s.; PE: 5.6-fold, Pϭ0.01) ( Figure 5A and 5B). Similar to phenylephrine, endothelin-1 did neither significantly induce GDF15 (ET-1: 1.2-fold, Pϭn.s.; PE: 1.2-fold, Pϭn.s.), nor heme oxidase I (ET-1: 1.0-fold, Pϭn.s.; PE: 0.9-fold, Pϭn.s.). In contrast, stimulation with Ang II caused a significant induction both of GDF15 (2.4-fold, PϽ0.01) and heme oxidase-1 (3.9-fold, PϽ0.001), supporting the notion that Ang II receptor signaling might be involved in the transduction of biomechanical stress 19, 27, 28 ( Figure 5C and 5D). Similarly, metallothionein-1 expression could not be stimulated by phenylephrine or endothelin-1, yet was significantly induced by Ang II (2.6-fold, PϽ0.001, Figure 5E ). Several others of the previously identified stretch-dependent genes revealed a similar pattern, including cMyc, MaoA, VL30E, and CKS2 ( Figure S3 ).
Because even enriched neonatal cardiomyocytes are not completely devoid of other cell types, we also tested whether contaminating fibroblasts could have contributed to the observed stretch-specific gene expression. Thus, neonatal rat fibroblasts were expanded in vitro and subjected to stretch or treatment with 100 nmol/L Ang II. We again tested expression of several genes found to be upregulated in stretched cardiomyocytes, including GDF-15, HMOX1, and Mt1a. None of these transcripts were found to be significantly induced in fibroblasts (data not shown), suggesting that the observed stretch-dependent regulation is cardiomyocyte-specific. Next, we were asking whether upregulation of the stretchspecific subset of genes is dependent on Ang II receptor 1a signaling. Thus, biaxially stretched neonatal cardiomyocytes were treated with the AT 1 -receptor blocker irbesartan (100 nmol/L) and analyzed for changes in the stretch-induced gene expression pattern ( Figure 6 ). Irbesartan significantly attenuated stretch-induced cardiomyocyte hypertrophy (Ϫ60.1%, PϽ0.05; Figure 6A ). Moreover, irbesartan significantly reduced the expression of BNP, GDF15, and heme oxidase-1 ( Figure 6B through 6D) . BNP expression was reduced by 38.3% (PϽ0.001, Figure 6B ). The abundance of GDF15 mRNA was decreased by 65.9% (PϽ0.001, Figure 6C ) on irbesartan treatment. Likewise, heme oxidase-1 expression was significantly blunted (Ϫ45.6%, PϽ0.001, Figure 6D ) by irbesartan, whereas ANF ( Figure 6E ) and Mt1a induction ( Figure 6F) were not altered. Taken together, these data suggest that at least in a subset of stretch-responsive genes, biomechanical stress is transduced via the Ang II receptor.
Discussion
Biomechanical stress leads to the induction of cardiomyocyte hypertrophy which is accompanied by an increase in cell size, enhanced sarcomeric organization, and induction of the "fetal" gene program. Yet, it is unknown, whether the molecular signals activated by "stretch" differ from other hypertrophic stimuli, ie, endogenous neurohumoral agonists.
To our knowledge, the present study is the first genomewide analysis of the gene expression pattern of stretched Strong stretch-specific upregulation of F, metallothionein 1a (Mt1a), G, heme oxidase-1 (Hmox1) and the cytokine H, growth and differentiation factor 15 (GDF15 or Mic-1). I and J, Representative Western blot analysis of the expression level of GDF15 and heme oxidase 1 protein. Stretch induced GDF15 and heme oxidase 1, whereas the expression levels on phenylephrine stimulation remained unchanged. In both cases, ␣-tubulin staining served as loading control. K-O, Expression levels of genes downregulated on stretch, including Lipocalin-2 (K), connexin40 (Gja5, L), the cell adhesion molecule VCAM1 (M), and the phospholipase group 2A (N). All genes were found to be repressed by both stretch and phenylephrine. Levels of significance: *PϽ0.05, †PϽ0.01, ‡PϽ0.001.
cardiomyocytes in comparison with pharmacological inducers of cardiomyocyte hypertrophy. Remarkably, only a total of 185 genes of more than 28 000 genes covered by the Affymetrix 230.2 chip were significantly regulated on stretch when adjusting the level of significance to a post-hoc probability of Ͼ99%. In contrast, phenlyephrine led to a broader alteration of gene expression with differential regulation of 450 genes when applying the same statistical criteria. Both biomechanical stretch and stimulation with the ␣-adrenergic agonist phenylephrine led to a comparable degree of hypertrophy and the induction of the fetal gene program (including upregulation of ANF, BNP, FHL1, and several other genes), pointing to shared mechanisms in the development of hypertrophy. However, we also identified a subset of 24 genes with stretch-specific regulation, again suggesting that stretchinduced hypertrophy is mediated at least in part by a specific gene expression program.
We verified differential regulation of several candidates for stretch-specific regulation by real-time PCR and found that HSP70, metallothionein-1, heme oxidase I, and GDF15 displayed the highest stretch specificity (Figure 4a ). Metallothionein-1 is an antioxidative protein, which renders cardiomyocytes resistant against oxidative stress. 29 When overexpressed in a cardiac-specific manner, metallothionein is able to diminish the cardiotoxicity of doxorubicin. 30 Furthermore, induction of endogenous metallothionein expression by administration of zinc protects mice against the development of diabetic or alcoholic cardiomyopathy. 31, 32 Similarly, upregulation of metallothionein mediates the cardioprotective effects of STAT3 in an ischemia-reperfusion model. 33 One could thus hypothesize that metallothionein protects cardiomyocytes from reactive oxygen species induced by mechanical stress. 34 Similarly, the highly induced heme oxidase I (HMOX1) is known as a cardioprotective factor as well. It degrades heme to biliverdin, iron, and carbon monoxide. 35 Mice with heterozygous disruption of the HMOX1 gene are sensitized for ischemia-reperfusion injury, 36 whereas overexpression of HMOX1 in the heart attenuates the detrimental effects of ischemia and reperfusion. 37 HMOX1 is also sufficient to inhibit Ang II-induced cardiac hypertrophy by a bilirubin-mediated inhibition of reactive oxygen species. 38 The p38 and extracellular signal-regulated kinase (ERK) 1/2 MAP kinases and the Calcineurin/NFAT pathway were identified as principal targets of the antihypertrophic actions of HMOX1. 39 The induction of heme oxidase I by biomechanical stress could thus represent a counteracting mechanism to prevent pathological hypertrophy.
Another interesting finding is the strong and stretchspecific upregulation of the cytokine growth and differentiation factor 15 (GDF15) which belongs to the transforming growth factor (TGF)␤ superfamily. 40 At baseline, GDF15 is only detectable in liver and placenta. 40 , 41 Yet, it has recently been shown to be strongly inducible in the heart on pathological stimuli such as myocardial infarction and pressure overload. 42,43 GDF15-deficient mice subjected to ischemiareperfusion injury exhibited increased infarct sizes as well as an increase in apoptosis. Conversely, recombinant GDF15 protects cardiomyocytes from apoptosis via PI3K-and AKTdependent mechanisms. 43 Likewise, transgenic overexpression of GDF15 in the heart blunts pressure overload-induced hypertrophy, whereas GDF15(Ϫ/Ϫ) mice displayed more pronounced cardiac hypertrophy on aortic banding. In cultured myocytes, the antihypertrophic properties of GDF15 appeared to be mediated via SMAD-dependent pathways. These findings led the authors to propose that GDF15 is a cytokine released in an auto-or paracrine way that displays antihypertrophic and cardioprotective features. The experimental settings (remodeling after ischemia, aortic banding) in which GDF15 has been described to be induced 42,43 are consistent with a higher wall tension resulting in increased biomechanical stress. Thus, these in vivo findings are consistent with our results that HMOX1 and GDF15 are preferentially regulated by stretch.
To further underscore the stretch-specificity of Mt1a/b, HMOX1, and GDF15, we also showed that not only phenylephrine but also endothelin-1 failed to significantly induce the transcription of these genes ( Figure 5C ). In contrast, stimulation with Ang II led to upregulation of all 3 transcripts. Stretch-induced induction of HMOX1 and GDF15 could be significantly blunted by irbesartan, suggesting that the angiotensin receptor plays a critical role in mediating biomechanical stress signals. However, we cannot exclude that endothelin-1 also contributes to stretch-dependent signaling, 20 because we found c-myc to be induced by endothelin as well, albeit to a lesser degree than by Ang II. Moreover, signal transduction in response to phasic versus static stretch may differ, as previous reports have shown that phasic stretch is not only mediated by Ang II but also endothelin-1. 44 How could the Ang II receptor signaling pathway modulate stretch-specific gene expression? How can the angiotensin-II pathway be distinct from the signaling pathways used by ET1 and PE, given that their receptors also couple to the G q/11 G proteins? Interestingly, the angiotensin type 1 receptor (AT1R) does not only couple to G q/11 or infrequently to G i , 45 but also to "unconventional" G protein-independent signaling mechanisms. 46 The cytoplasmic domains of the AT1R interacts with multiple signaling proteins. 47 Besides the G ␣ coupling site, the AT1R can bind to JAK2 in an agonistdependent fashion leading to STAT1/2 activation. 48 Similarly, the AT1R binds to phospholipase Cgamma1 presumably via SHP-2, 49 to ATRAPs (AT1R associated proteins), 50,51 and a novel protein called GLP, a GDP-/GTP exchange factor protein. 52 Cardiac overexpression of an AT1R deficient for G q /G i coupling leads to exaggerated hypertrophy, yet less apoptosis and fibrosis on chronic Ang II stimulation compared with transgenic mice overexpressing the wild-type receptor. 53 In an accompanying commentary, Rockman and coworkers 46 speculated that GRKs and ␤-arrestins might be good candidates for the mediation of the Gq/Gi-independent AT1R-signals, because their intracellular functions mimic the effects of the AT1R deficient for G protein coupling. 54 Very recently, Sadoshima's group also found that mice transgenic for an Ang II type 1 receptor mutant without the ability to activate the EGF-receptor did neither develop cardiac hypertrophy nor fibrosis on Ang II infusion. This effect was observed despite a normal activation of the G q G protein signaling cascade, 55 again supporting the notion that G protein independent signaling properties of the AT1R may promote cell growth and protection against cell death and fibrosis.
Perspectives
In summary, we provide a comprehensive analysis of the gene expression profile of stretched cardiomyocytes. This profile could clearly be differentiated from the expression pattern induced by pharmacological agents such as phenylephrine and endothelin-1, suggesting the existence of a biomechanical stress-specific gene program. Moreover, we demonstrate that this gene program is mediated, at least in part, by angiotensin receptor signaling. We speculate that stretch-specific gene expression is evoked by activation of the angiotensin II type 1 receptor and transmitted downstream partly in a G q/11 -independent fashion. 
RNA isolation and purification
Total RNA was isolated from NRVCMs using the TRIzol TM reagent (Invitrogen, Germany)
according to the manufacturer's protocol. RNA was resuspended in DEPC-treated H 2 O (Sigma). RNA integrity and purity were electrophoretically verified by ethidium bromide staining and measurement of OD 260 /OD 280 absorption ratios. Total RNA was pooled from several preparations (n=5 per group) and purified from contaminating genomic DNA by a DNase I digestion (AMPD1, Sigma).
Affymetrix Rat 230.2 microarrays
Affymetrix expression profiling was carried out at the German Ressource Center for Genome
Research (RZPD; Berlin, Germany). Briefly, integrity of RNA was checked using an Agilent Bioanalyzer (Eukaryote total RNA assay) followed by cDNA synthesis and in vitro transcription with Ambion's Message Amp kit according the manufacturer's instructions.
cRNA was subjected to quality control using the Bioanalyzer with the mRNA smear nano assay. Final cRNA concentration was 60 ng/µl. Hybridization was carried out for 16-18 hours in the Affymetrix Oven 640 at 60 rpm and 45°C. Subsequent washing and staining was performed with a fluidics station (Gene Chip® Fluidics station 400, Affymetrix) and controlled by Affymetrix GeneChip Operating System (GCOS). The scanning process and primary data analysis was done with the Affymetrix GeneChip Scanner 3000 controlled with GCOS.
Microarray data analysis
Microarray data (n=2 per condition) were normalized by the variance stabilization method of Huber et al. 3 . To select differentially expressed genes, an empirical Bayes analysis was carried out [4] [5] [6] . This analysis accounts for small sample numbers by introducing parametric estimates of the distribution of intensities arising from different probe sets across the samples.
A gamma-gamma model was assumed according to Kendziorski et al. 5 . The assumptions were checked by plotting the coefficient of variation versus the intensity as well as quantilequantile plots of empirical distributions versus Gamma distribution (data not shown). Genes were selected when the posterior probability of differential expression was greater than 0.99. 
Immunofluorescence experiments
Cardiac myocytes were fixed in 4% paraformaldehyde (Sigma) in PBS, permeabilized with 0.3% Triton X-100 (Sigma, T9284) and blocked for 1.5 h with 2% bovine serum albumine (Sigma). Sarcomeric α-actinin was detected using a monoclonal antibody (Sigma; 1:200).
ANF was detected with a polyclonal antibody (Peninsula, USA; 1:100 
